文献速递冠心病

美国650万癌症患者急性心肌梗死的治疗与结局

Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA.
PubMed 文献 · Eur Heart J · 2020-01-01

基于美国国家住院样本数据库2004至2014年6 563 255例急性心肌梗死患者,其中现患癌症186 604例、既往癌症409 697例。癌症患者接受侵入性治疗比例更低,肺癌患者院内死亡风险最高,转移性癌症患者院内结局更差,既往癌症不影响生存。

要点

  • 癌症合并急性心肌梗死患者接受PCI等侵入性治疗的比例明显低于无癌症患者。
  • 肺癌患者院内死亡、心脑血管并发症及卒中风险最高,结肠癌出血风险最高。
  • 无论癌症类型,存在转移均与更差的院内结局相关,既往癌症未显著影响生存。

核心结论

  • 合并癌症诊断与急性心肌梗死的保守药物管理策略及更差临床结局相关,结局因癌症类型和转移状态而异。

研究设计与样本

  • 回顾性分析美国国家住院样本数据库2004至2014年6 563 255例急性心肌梗死患者,其中无癌症5 966 955例、现患癌症186 604例、既往癌症409 697例。

主要发现

  • 无癌症患者43.9%接受经皮冠状动脉介入治疗,肺癌患者仅21.0%接受该治疗。
  • 肺癌与最高院内死亡风险相关(OR 2.71,95%CI 2.62-2.80)、主要心脑血管并发症(OR 2.38,95%CI 2.31-2.45)及卒中(OR 1.91,95%CI 1.80-2.02)。
  • 结肠癌与最高出血风险相关(OR 2.82,95%CI 2.68-2.98)。
  • 存在转移与更差院内结局相关,既往癌症未显著影响生存(OR 0.90,95%CI 0.89-0.91)。
  • 前列腺癌、乳腺癌、结肠癌和肺癌为最常见的四种癌症类型,癌症患者年龄更大且合并症更多。

临床怎么用

  • 对合并癌症的急性心肌梗死患者应综合评估癌症类型与转移状态,采取多学科且以患者为中心的管理策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The aim of this study is to evaluate temporal trends, treatment, and clinical outcomes of patients who present with an acute myocardial infarction (AMI) and have a current or historical diagnosis of cancer, according to cancer type and presence of metastases. METHODS AND RESULTS: Data from 6 563 255 patients presenting with an AMI between 2004 and 2014 from the US National Inpatient Sample (NIS) database were analysed. A total of 5 966 955 had no cancer, 186 604 had current cancer, and 409 697 had a historical diagnosis of cancer. Prostate, breast, colon, and lung cancer were the four most common types of cancer. Patients with cancer were older with more comorbidities. Differences in invasive treatment were noted, 43.9% received percutaneous coronary intervention (PCI) in patients without cancer, whilst only 21.0% of patients with lung cancer received PCI. Lung cancer was associated with the highest in-hospital mortality [odds ratio (OR) 2.71, 95% confidence interval (CI) 2.62-2.80], major adverse cardiovascular and cerebrovascular complications (OR 2.38, 95% CI 2.31-2.45), and stroke (OR 1.91, 95% CI 1.80-2.02), while colon cancer was associated with highest risk of bleeding (OR 2.82, 95% CI 2.68-2.98). Irrespective of the type of cancer, presence of metastasis was associated with worse in-hospital outcomes, and historical cancer did not adversely impact on survival (OR 0.90, 95% CI 0.89-0.91). CONCLUSION: A concomitant cancer diagnosis is associated with a conservative medical management strategy for AMI, and worse clinical outcomes, compared to patients without cancer. Survival and clinical outcomes in the context of AMI vary significantly according to the type of cancer and metastasis status. The management of this high-risk group is challenging and requires a multidisciplinary and patient-centred approach to improve their outcomes.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Bharadwaj A, Potts J, Mohamed MO, et al. Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA. Eur Heart J. 2020. PMID: 31800032. doi:10.1093/eurheartj/ehz851

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。